Enrofloxacin

Enrofloxacin is a broad-spectrum antibiotic belonging to the fluoroquinolone class of medications. It is primarily used to treat bacterial infections in various parts of the body, including the respiratory tract, urinary tract, skin, and soft tissues. Enrofloxacin is effective against a wide range of bacteria, including Gram-positive and Gram-negative strains, as well as anaerobic organisms.
The medication works by inhibiting bacterial DNA synthesis, preventing the bacteria from replicating and ultimately leading to their death. Enrofloxacin is available in various forms, such as oral tablets, oral suspension, and injectable solutions, allowing for flexible administration options based on the severity of the infection and the patient’s condition.
Enrofloxacin is commonly prescribed for the treatment of lower respiratory tract infections, such as bronchitis and pneumonia, as well as urinary tract infections, including cystitis and pyelonephritis. It may also be used for skin and soft tissue infections, such as cellulitis, and for treating bacterial infections in the gastrointestinal tract.
Before prescribing Enrofloxacin, healthcare professionals should consider the patient’s medical history, the severity of the infection, and the potential for antibiotic resistance. As with all antibiotics, complete the full course of treatment, even if symptoms improve before the medication is finished, to ensure the infection is fully eradicated and to reduce the risk of antibiotic resistance.